EPISODE · May 18, 2022 · 30 MIN
In Conversation: Elisabeth Bjork
from The Leaders Council Podcast
Elisabeth Bjork heads up AstraZeneca’s late-stage development within cardiovascular, renal and metabolic diseases (CVRM), and is responsible for late-stage clinical development, large outcomes programs, major global filings and health authority interactions (FDA, EMA, Japan, China).Elisabeth’s focus is to get life-changing medications to patients as early as possible to improve their quality and longevity of life.
Embed this episode
NOW PLAYING
In Conversation: Elisabeth Bjork
0:00
30:23
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Leaders Council Podcast?
This episode is 30 minutes long.
When was this The Leaders Council Podcast episode published?
This episode was published on May 18, 2022.
Can I download this The Leaders Council Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!